These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 20847163)

  • 1. Multicenter evaluation of a standardized protocol for rest and acetazolamide cerebral blood flow assessment using a quantitative SPECT reconstruction program and split-dose 123I-iodoamphetamine.
    Iida H; Nakagawara J; Hayashida K; Fukushima K; Watabe H; Koshino K; Zeniya T; Eberl S
    J Nucl Med; 2010 Oct; 51(10):1624-31. PubMed ID: 20847163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative assessment of rest and acetazolamide CBF using quantitative SPECT reconstruction and sequential administration of (123)I-iodoamphetamine: comparison among data acquired at three institutions.
    Yamauchi M; Imabayashi E; Matsuda H; Nakagawara J; Takahashi M; Shimosegawa E; Hatazawa J; Suzuki M; Iwanaga H; Fukuda K; Iihara K; Iida H
    Ann Nucl Med; 2014 Nov; 28(9):836-50. PubMed ID: 25001261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reproducibility of cerebral blood flow assessment using a quantitative SPECT reconstruction program and split-dose 123I-iodoamphetamine in institutions with different γ-cameras and collimators.
    Yoneda H; Shirao S; Koizumi H; Oka F; Ishihara H; Ichiro K; Kitahara T; Iida H; Suzuki M
    J Cereb Blood Flow Metab; 2012 Sep; 32(9):1757-64. PubMed ID: 22617648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of tissue heterogeneity on cerebral vascular response to acetazolamide stress measured by an I-123-IMP autoradiographic method with single-photon emission computed tomography.
    Ito H; Shidahara M; Inoue K; Goto R; Kinomura S; Taki Y; Okada K; Kaneta T; Sato K; Sato T; Fukuda H
    Ann Nucl Med; 2005 Jun; 19(4):251-60. PubMed ID: 16097633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative mapping of basal and vasareactive cerebral blood flow using split-dose 123I-iodoamphetamine and single photon emission computed tomography.
    Kim KM; Watabe H; Hayashi T; Hayashida K; Katafuchi T; Enomoto N; Ogura T; Shidahara M; Takikawa S; Eberl S; Nakazawa M; Iida H
    Neuroimage; 2006 Dec; 33(4):1126-35. PubMed ID: 17035048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Development of quantification analysis software for measuring regional cerebral blood flow by the modified split-dose method with (123)I-IMP before and after acetazolamide loading].
    Nagaki A; Kobara K; Matsutomo N
    Nihon Hoshasen Gijutsu Gakkai Zasshi; 2003 Dec; 59(12):1573-9. PubMed ID: 15001874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Quantitative measurements of regional cerebral blood flow using technetium-99m-L,L-ECD SPECT activated with acetazolamide: fundamental study of measurement's accuracy, comparison with 123I-IMP ARG method].
    Itoh S; Iwata A; Watanabe Y; Kitano S; Imai S; Yoshiya K
    Kaku Igaku; 1997 Nov; 34(11):1047-53. PubMed ID: 9455046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative measurement of regional cerebrovascular reactivity to acetazolamide using 123I-N-isopropyl-p-iodoamphetamine autoradiography with SPECT: validation study using H2 15O with PET.
    Ogasawara K; Ito H; Sasoh M; Okuguchi T; Kobayashi M; Yukawa H; Terasaki K; Ogawa A
    J Nucl Med; 2003 Apr; 44(4):520-5. PubMed ID: 12679394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Technetium-99m-HMPAO, technetium-99m-ECD and iodine-123-IMP cerebral blood flow measurements with pharmacological interventions in primates.
    Dormehl IC; Oliver DW; Langen KJ; Hugo N; Croft SA
    J Nucl Med; 1997 Dec; 38(12):1897-901. PubMed ID: 9430465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of scatter and attenuation correction on quantitative assessment of regional cerebral blood flow with SPECT.
    Iida H; Narita Y; Kado H; Kashikura A; Sugawara S; Shoji Y; Kinoshita T; Ogawa T; Eberl S
    J Nucl Med; 1998 Jan; 39(1):181-9. PubMed ID: 9443759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Validation and optimization of the use of standardized arterial input function in N-isopropyl-p[123I]iodoamphetamine cerebral blood flow SPECT].
    Ogura T; Takikawa S; Saito H; Nakazawa M; Shidahara M; Iida H
    Kaku Igaku; 1999 Oct; 36(8):879-90. PubMed ID: 10586549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acetazolamide challenge and technetium-99m-ECD versus iodine-123-IMP SPECT in chronic occlusive cerebrovascular disease.
    Ohnishi T; Yano T; Nakano S; Jinnouchi S; Nagamachi S; Flores LI; Nakahara H; Watanabe K
    J Nucl Med; 1997 Sep; 38(9):1463-7. PubMed ID: 9293809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of rate of increase in SPECT counts in one-day method of N-isopropyl-4-iodoamphetamine [123I] SPECT studies at rest and after acetazolamide challenge using a method for estimating time-dependent distribution at rest.
    Kawamura Y; Ashizaki M; Saida S; Sugimoto H
    Ann Nucl Med; 2008 Jun; 22(5):457-63. PubMed ID: 18600426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correction of photon attenuation and collimator response for a body-contouring SPECT/CT imaging system.
    Seo Y; Wong KH; Sun M; Franc BL; Hawkins RA; Hasegawa BH
    J Nucl Med; 2005 May; 46(5):868-77. PubMed ID: 15872362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a double-injection method for sequential measurement of cerebral blood flow with iodine-123-iodoamphetamine.
    Nishizawa S; Yonekura Y; Tanaka F; Fujita T; Tsuchimochi S; Ishizu K; Okazawa H; Tamaki N; Konishi J
    J Nucl Med; 1995 Jul; 36(7):1339-45. PubMed ID: 7790965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perfusion computed tomography evaluation of cerebral hemodynamic impairment in patients with unilateral chronic steno-occlusive disease: a comparison with the acetazolamide challenge 99mTc-hexamethylpropyleneamine oxime single-photon emission computed tomography.
    Kim E; Sohn CH; Na DG; Kim JE; Chang KH; Kim JH; Jeon SJ
    J Comput Assist Tomogr; 2009; 33(4):546-51. PubMed ID: 19638847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validity of the γ-Ray Evaluation with iodoamphetamine for Cerebral Blood Flow Assessment (REICA) method for quantification of cerebral blood flow including acetazolamide challenge test.
    Miyazaki Y; Kameyama M; Nakamizo A; Noguchi T; Tabata N
    Ann Nucl Med; 2022 Mar; 36(3):279-284. PubMed ID: 34973145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acetazolamide reactivity on 123I-IMP single photon emission computed tomography in patients with major cerebral artery occlusive disease: correlation with positron emission tomography parameters.
    Hirano T; Minematsu K; Hasegawa Y; Tanaka Y; Hayashida K; Yamaguchi T
    J Cereb Blood Flow Metab; 1994 Sep; 14(5):763-70. PubMed ID: 8063872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation studies of iodine-123-iodoamphetamine as a cerebral blood flow tracer using emission tomography.
    Greenberg JH; Kushner M; Rango M; Alavi A; Reivich M
    J Nucl Med; 1990 Aug; 31(8):1364-9. PubMed ID: 2384805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Scatter Correction of Septal Penetration for
    Yamanaga T; Katayama Y; Nakama S; Kakimi A; Nagahata T; Kishimoto K; Ichida T; Higashiyama S; Kawabe J; Shiomi S
    Nihon Hoshasen Gijutsu Gakkai Zasshi; 2017; 73(10):1028-1038. PubMed ID: 29057774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.